186 related articles for article (PubMed ID: 2549113)
1. Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.
Fioretti P; Cagnacci A; Paoletti AM; Gambacciani M; Soldani R; Mauro GA; Spinetti A; Melis GB
J Endocrinol Invest; 1989 May; 12(5):295-301. PubMed ID: 2549113
[TBL] [Abstract][Full Text] [Related]
2. Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.
Melis GB; Cagnacci A; Gambacciani M; Paoletti AM; Moggi L; Fioretti P
J Clin Endocrinol Metab; 1988 May; 66(5):964-7. PubMed ID: 2834413
[TBL] [Abstract][Full Text] [Related]
3. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
[TBL] [Abstract][Full Text] [Related]
4. Interaction between veralipride and the endogenous opioid system in the regulation of body temperature in postmenopausal women.
Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
Life Sci; 1988; 42(5):547-53. PubMed ID: 3339948
[TBL] [Abstract][Full Text] [Related]
5. Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal women.
Melis GB; Cagnacci A; Gambacciani M; Paoletti AM; Caffi T; Fioretti P
Neuroendocrinology; 1988 Feb; 47(2):159-63. PubMed ID: 2830551
[TBL] [Abstract][Full Text] [Related]
6. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
Cetel NS; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
[TBL] [Abstract][Full Text] [Related]
7. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
8. Evidence for endogenous opioid modulation of serum luteinizing hormone and prolactin in the steer.
Peck DD; Thompson FN; Stuedemann JA; Leshin LS; Kiser TE
J Anim Sci; 1988 Dec; 66(12):3197-201. PubMed ID: 3230079
[TBL] [Abstract][Full Text] [Related]
9. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
Cagnacci A; Melis GB; Soldani R; Bonuccelli U; Piccini P; Napolitano A; Muratorio A; Fioretti P
Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
[TBL] [Abstract][Full Text] [Related]
10. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
Shoupe D; Montz FJ; Lobo RA
J Clin Endocrinol Metab; 1985 Jan; 60(1):178-83. PubMed ID: 2981084
[TBL] [Abstract][Full Text] [Related]
11. [Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
De Cecco L; Venturini PL; Alibrandi MP; Grondona AL; Morano S; Penna L; Campanella G; Ragni N
Rev Fr Gynecol Obstet; 1985 Feb; 80(3):152-5. PubMed ID: 3922034
[TBL] [Abstract][Full Text] [Related]
12. The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women.
Reid RL; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1983 Dec; 57(6):1107-10. PubMed ID: 6313728
[TBL] [Abstract][Full Text] [Related]
13. Sex steroids modulate prolactin response to naloxone in postmenopausal women.
Melis GB; Gambacciani M; Paoletti AM; Mais V; Cagnacci A; Petacchi FD; Fioretti P
Neuroendocrinology; 1985 Aug; 41(2):138-41. PubMed ID: 2995857
[TBL] [Abstract][Full Text] [Related]
14. Effects of melatonin on luteinizing hormone secretion in anestrous ewes following dopamine and opiate receptor blockade.
Misztal T; Romanowicz K; Barcikowski B
Anim Reprod Sci; 2004 Apr; 81(3-4):245-59. PubMed ID: 14998651
[TBL] [Abstract][Full Text] [Related]
15. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
Gilbeau PM; Almirez RG; Holaday JW; Smith CG
J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
[TBL] [Abstract][Full Text] [Related]
16. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy.
De Leo V; Petraglia F; Bruno MG; Lanzetta D; Inaudi P; D'Antona N
Gynecol Obstet Invest; 1989; 27(2):94-8. PubMed ID: 2499519
[TBL] [Abstract][Full Text] [Related]
17. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
18. Relation between luteinizing hormone and prolactin pulses in ovariectomized rats with or without dopamine inhibition.
Pohl CR; Weiner RI; Smith MS
Endocrinology; 1988 Sep; 123(3):1591-7. PubMed ID: 3402398
[TBL] [Abstract][Full Text] [Related]
19. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
[TBL] [Abstract][Full Text] [Related]
20. Neonatal organization of the brain opioid systems controlling prolactin and luteinizing hormone secretion.
Limonta P; Dondi D; Maggi R; Martini L; Piva F
Endocrinology; 1989 Feb; 124(2):681-6. PubMed ID: 2912695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
